Wednesday, June 17, 2020 12:17:09 AM
Iwasadiver, appreciate your response. I haven’t looked into the details on HCQ enough to make a firm judgment but I suspect zinc is important, perhaps critical, to the protocol, as well as zpac. There seem to be doctors having success but of course the trial results are muddy. I wouldn’t be surprised if there was monkey business going on with some of the trials. I hope to provide a couple of examples in the future.
Time will tell and it will be useful in updating our models of the world if necessary when the truth is finally nailed down.
BTW, I don’t have much good to say about the current state of medicine, in general. However, I believe that acute care, which you specialize in, is one of the few areas that stand out positively. Obviously if I’ve been shot in one of these crazy riots I would try to stumble towards your ER and collapse in the doorway looking for you to save my life.
It’s in chronic illness, especially, but not limited to cancer care, that the edifice is rotten top to bottom. It’s been a process that goes back over 100 years so most doctors aren’t even aware of the situation. It’s just the air we breathe these days, and if you only know the San Fernando Valley it seems like the way things should be.
It seems like it works once you’re in need of oxygen or ventilation though perhaps there is something specific about the dosage (they mentioned low dose). The article hints at ARDS as a possible scenario where it might work but without actually saying it.
In any case, this seems like great news to me, even if it steps on my investment in ATHX in the short term. They have a covid-based ARDS trial in progress — still thinking through the short term implications of these results. I felt their shift to focus on covid-specific ARDS might have been a tactical error when they announced it but still too early to say.
Dexamethasone proves first life-saving drug:
https://www.bbc.com/news/health-53061281
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM